1 / 5

The 2 nd IGFD Forum

The 2 nd IGFD Forum. 13 th May 2009, Barcelona. Welcome & Objectives. Prof Martin Savage, Co-Chair. Sharing Clinical Experience & Opinions on Severe Primary IGF Deficiency (SPIGFD). Welcome to colleagues from Europe & US The 2 nd IGFD Forum: Opportunity to review latest data

steffie
Télécharger la présentation

The 2 nd IGFD Forum

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The 2nd IGFD Forum 13th May 2009, Barcelona

  2. Welcome & Objectives Prof Martin Savage, Co-Chair

  3. Sharing Clinical Experience & Opinions on Severe Primary IGF Deficiency (SPIGFD) • Welcome to colleagues from Europe & US • The 2nd IGFD Forum: • Opportunity to review latest data • Advice on identification & diagnosis of patients • Discussion on practical management of the condition • Above all, chance to share experience& exchange views in open discussion

  4. The 2nd IGFD Forum • Since the 1st IGFD Forum in Chantilly in November 2007, clinicians have gained experience in diagnosis of SPIGFD and treatment with Increlex. We will draw on this experience. • Advances in three particular areas related to SIGFD; prevalence in short stature patients, genetic diagnoses, and new therapeutic studies with Increlex. • SPIGFD in the continuum of defects of the GH-IGF-I axis causing short stature.

  5. Paradigm of GH secretion and GH sensitivity in short stature GH secretion Laron syndrome Severe Primary IGF-I Deficiency Idiopathic short stature GH secretion abnormalities GH Deficiency 0 GH sensitivity

More Related